Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 25, 2011

 

 

Medtronic, Inc.

(Exact name of Registrant as Specified in its Charter)

 

 

 

Minnesota   1-7707   41-0793183

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

710 Medtronic Parkway Minneapolis, Minnesota   55432
(Address of principal executive offices)   (Zip Code)

(Registrant’s telephone number, including area code): (763) 514-4000

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.07 Submission of Matters to a Vote of Security Holders

The 2011 Annual Meeting of Shareholders of Medtronic, Inc. (the “Company”) was held on August 25, 2011. The votes cast with respect to each item of business properly presented at the meeting are as follows:

 

 

The shareholders elected each of the eleven nominees to the Board of Directors to serve for one-year terms, as follows:

 

     For      Withheld      Broker Non-Vote  

Richard H. Anderson

     722,886,180         29,882,172         114,631,853   

David L. Calhoun

     475,257,231         277,511,121         114,631,853   

Victor J. Dzau, M.D.

     744,463,905         8,304,447         114,631,853   

Omar Ishrak

     724,805,149         27,963,203         114,631,853   

Shirley Ann Jackson, Ph.D.

     678,889,286         73,879,066         114,631,853   

James T. Lenehan

     744,829,280         7,939,072         114,631,853   

Denise M. O’Leary

     739,826,442         12,941,910         114,631,853   

Kendall J. Powell

     649,194,876         103,573,476         114,631,853   

Robert C. Pozen

     742,896,923         9,871,429         114,631,853   

Jean-Pierre Rosso

     720,192,760         32,575,592         114,631,853   

Jack W. Schuler

     611,656,100         141,112,252         114,631,853   

 

 

The shareholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the 2012 fiscal year.

 

For

     859,736,337   

Against

     6,654,794   

Abstain

     1,009,074   

Broker Non-Vote

     N/A   

 

 

The shareholders adopted the non-binding resolution approving the compensation of the Company’s named executive officers as described in the Company’s 2011 proxy statement.

 

For

     558,860,528   

Against

     191,156,521   

Abstain

     2,751,303   

Broker Non-Vote

     114,631,853   

 

 

The shareholders cast non-binding votes to determine the frequency (whether annual, biennial or triennial) with which the shareholders will be entitled to have a future advisory vote on the compensation of the Company’s named executive officers. A plurality of shareholders favored an annual advisory vote on the compensation of the Company’s named executive officers. Based on the Board of Directors’ recommendation in the Company’s 2011 proxy statement and the voting results, the Company has determined to hold an advisory vote on executive compensation annually.

 

1 Year

     643,748,639   

2 Years

     2,524,105   

3 Years

     103,175,722   

Abstain

     3,319,886   

Broker Non-Vote

     N/A   


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  MEDTRONIC, INC.
  By  

/s/ Gary L. Ellis

Date: August 30, 2011     Gary L. Ellis
    Senior Vice President and Chief Financial Officer